The ARDF Annual Open Grant Program
was established to fund research projects that develop alternative methods or utilize an alternative approach in research, testing or education. Over $4 million in grants have been awarded to date.
ARDF's new Alternatives in Research (AiR) Challenge
program will stimulate innovation in alternative methods, focused on biomedical research.
ARDF works to promote alternatives through the sponsorship of scientific meetings across the globe, participation in regulatory and industry meetings, and providing free consultations with media representatives, scientists, and government officials. ARDF also engages in legal advocacy to accelerate acceptance and utilization of alternative methods, such as its successful legal petitions to National Institutes of Health to require its grantees to produce monoclonal antibodies via in vitro
methods, as opposed to traditional mouse ascites.
Recognizing individuals in the scientific community who have made extraordinary contributions to the advancement of alternatives, ARDF rewards scientists through its William and Eleanor Cave Award
Sue A. Leary | President
Sue A. Leary has been President and CEO of ARDF since 1995. She has a B.S. in Biology and M.S. in Nonprofit Management. Her career has focused on coordination of programs and services; education and advocacy; administration and planning; and membership development in nonprofit organizations. Since 1995, she has served as President of the Alternatives Research & Development Foundation (ARDF) and its affiliate, American Anti-Vivisection Society (AAVS). Ms. Leary is Executive Editor of the AV Magazine, and Chair of the Coalition for Consumer Information on Cosmetics (CCIC), which operates the Leaping Bunny Program. She has served on a number of boards, including the Global Federation of Animal Sanctuaries.
Angela N. Hvitved | Scientific Consultant
Angela N. Hvitved, PhD, MA joined ARDF as a Program Director in 2022. Previously she worked as a scientific review consultant managing review for clinical trial proposals. Before moving into scientific review and administration, she served as a Public Health Advisor at the U.S. Department of Health and Human Services (HHS) Office for Human Research Protections (OHRP). Prior to that, she worked as a Health Science Policy Analyst at the National Institutes of Health (NIH), where she covered a broad range of policy areas. Dr. Hvitved received a PhD in Biochemistry and Cell Biology from Rice University and a MA in Philosophy from Johns Hopkins University.
Board of Directors
Sue A. Leary | President
Joseph Ludwig | Vice President
Aaron McIntyre | Treasurer
Denise Cowie | Secretary
Nadia Adawi, Esq.